176 related articles for article (PubMed ID: 25216327)
21. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
[TBL] [Abstract][Full Text] [Related]
22. Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model.
Wang Y; Shan Q; Hou G; Zhang J; Bai J; Lv X; Xie Y; Zhu H; Su S; Li Y; Zi J; Lin L; Han W; Zhao X; Wang H; Xu N; Wu L; Lou X; Liu S
J Proteomics; 2016 Jan; 132():31-40. PubMed ID: 26581642
[TBL] [Abstract][Full Text] [Related]
23. Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals.
Thorsen SB; Lundberg M; Villablanca A; Christensen SL; Belling KC; Nielsen BS; Knowles M; Gee N; Nielsen HJ; Brünner N; Christensen IJ; Fredriksson S; Stenvang J; Assarsson E
J Transl Med; 2013 Oct; 11():253. PubMed ID: 24107468
[TBL] [Abstract][Full Text] [Related]
24. Pattern of Melanotransferrin Expression in Human Colorectal Tissues: An Immunohistochemical Study on Potential Clinical Application.
Duś-Szachniewicz K; Ostasiewicz P; Woźniak M; Kołodziej P; Wiśniewski JR; Ziółkowski P
Anticancer Res; 2015 Dec; 35(12):6551-61. PubMed ID: 26637869
[TBL] [Abstract][Full Text] [Related]
25. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
[TBL] [Abstract][Full Text] [Related]
26. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
[TBL] [Abstract][Full Text] [Related]
27. A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry.
Jones JJ; Wilcox BE; Benz RW; Babbar N; Boragine G; Burrell T; Christie EB; Croner LJ; Cun P; Dillon R; Kairs SN; Kao A; Preston R; Schreckengaust SR; Skor H; Smith WF; You J; Hillis WD; Agus DB; Blume JE
Clin Colorectal Cancer; 2016 Jun; 15(2):186-194.e13. PubMed ID: 27237338
[TBL] [Abstract][Full Text] [Related]
28. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
29. Circulating levels of periostin may help identify patients with more aggressive colorectal cancer.
Ben QW; Zhao Z; Ge SF; Zhou J; Yuan F; Yuan YZ
Int J Oncol; 2009 Mar; 34(3):821-8. PubMed ID: 19212687
[TBL] [Abstract][Full Text] [Related]
30. Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.
Shin J; Kim G; Lee JW; Lee JE; Kim YS; Yu JH; Lee ST; Ahn SH; Kim H; Lee C
Cancer Sci; 2016 Jun; 107(6):828-35. PubMed ID: 27002480
[TBL] [Abstract][Full Text] [Related]
31. N-glycoprotein analysis discovers new up-regulated glycoproteins in colorectal cancer tissue.
Nicastri A; Gaspari M; Sacco R; Elia L; Gabriele C; Romano R; Rizzuto A; Cuda G
J Proteome Res; 2014 Nov; 13(11):4932-41. PubMed ID: 25247386
[TBL] [Abstract][Full Text] [Related]
32. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
33. Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer.
Tsai MH; Wu CC; Peng PH; Liang Y; Hsiao YC; Chien KY; Chen JT; Lin SJ; Tang RP; Hsieh LL; Yu JS
J Mol Med (Berl); 2012 Feb; 90(2):187-200. PubMed ID: 21997591
[TBL] [Abstract][Full Text] [Related]
34. Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages.
Abdulla MH; Valli-Mohammed MA; Al-Khayal K; Al Shkieh A; Zubaidi A; Ahmad R; Al-Saleh K; Al-Obeed O; McKerrow J
Oncol Rep; 2017 Jun; 37(6):3175-3180. PubMed ID: 28440429
[TBL] [Abstract][Full Text] [Related]
35. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
36. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
[TBL] [Abstract][Full Text] [Related]
37. Proteomic screening of potential N-glycoprotein biomarkers for colorectal cancer by TMT labeling combined with LC-MS/MS.
Gong Q; Zhang X; Liang A; Huang S; Tian G; Yuan M; Ke Q; Cai Y; Yan B; Wang J; Wang J
Clin Chim Acta; 2021 Oct; 521():122-130. PubMed ID: 34242638
[TBL] [Abstract][Full Text] [Related]
38. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.
Roessler M; Rollinger W; Mantovani-Endl L; Hagmann ML; Palme S; Berndt P; Engel AM; Pfeffer M; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
Mol Cell Proteomics; 2006 Nov; 5(11):2092-101. PubMed ID: 16893879
[TBL] [Abstract][Full Text] [Related]
39. Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray.
Matsubara J; Honda K; Ono M; Sekine S; Tanaka Y; Kobayashi M; Jung G; Sakuma T; Nakamori S; Sata N; Nagai H; Ioka T; Okusaka T; Kosuge T; Tsuchida A; Shimahara M; Yasunami Y; Chiba T; Yamada T
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2195-203. PubMed ID: 21828233
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
